Abstract

MicroRNAs (miRNAs) are known to play a part in regulating important cellular processes. They generally perform their regulatory function through their binding with mRNAs, ultimately leading to a repression of target protein expression levels. However, their roles in cellular processes are poorly understood due to the limited understanding of their specific cellular targets. Aberrant levels of miRNAs have been found in hepatocellular carcinoma (HCC) including miR-181a. Using bioinformatics analysis, cyclin-dependent kinase inhibitor 1B (CDKN1β) and transcriptional factor E2F7 were identified as potential targets of miR-181a. Validation analysis using surface plasmon resonance (SPR) showed a positive binding between miR-181a and the 3’UTRs of these two potential mRNA targets. In vivo luciferase assay further confirmed the positive miR-181a:mRNA bindings, where a significant decrease in luciferase activity was detected when HepG2 cells were co-transfected with the 3’UTR-containing reporter plasmids and miR-181a. The potential impact of miR-181a binding to its specific targets on the general cellular behavior was further investigated. Results showed that miR-181a significantly activated the MAPK/JNK pathway which regulates cell proliferation, supporting our recently reported findings. Inhibition of miR-181a, on the other hand, abolished the observed activation. Our findings open up a new approach in designing targeted functional analysis of miRNAs in cellular processes, through the identification of their cellular targets.

Highlights

  • Cancer is one of the top leading causes of mortality in the world today, accounting for approximately 7.6 million deaths in 2008 [1]

  • Genes implicated in cell proliferation, differentiation and apoptosis are involved in cancer initiation and subsequent progression [2]

  • We investigate the involvement of miR-181a in hepatocellular carcinoma (HCC), the third leading cause of cancer-related deaths, and its potential mRNA binding targets in HepG2 cells

Read more

Summary

Introduction

Cancer is one of the top leading causes of mortality in the world today, accounting for approximately 7.6 million deaths in 2008 [1]. MiRNAs form a subclass of small RNAs and are single-stranded, non-coding RNAs of 19–25 nucleotides in length, and are usually found in the intergenic regions or introns of the genome [3] They are able to regulate various physiologically important processes in the body such as cellular proliferation, differentiation, cell cycle, angiogenesis, metabolism, immune response and apoptosis, making them a key player in cancer [4]. 3% of the entire human genome encodes for miRNAs and they regulate up to 30% of human protein coding genes [5] Because they are able to regulate a large number of proteins, their abnormal expression often disrupts the functioning of the cell, either by activating oncogenes or deactivating tumor suppressor networks. This contributes to the initiation and progression of many human cancers

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call